Search Results - "Pavlovsky, Astrid"

Somatic hypermutation profiles in stereotyped IGHV4-34 receptors from South American chronic lymphocytic leukemia patients by Stanganelli, Carmen, Torres, Davi Coe, Ortega, Claudia, Márquez, María Elena, Remedi, Victoria, Cabrera, Juana, Mardaraz, Claudia, Galvano, Camila, Krzywinski, Andrea, Lang, Cecilia, Zanella, Lorena, Agriello, Evangelina, Bezares, Raimundo, Pavlovsky, Astrid, Pavlovsky, Miguel A., Oppezzo, Pablo, Slavutsky, Irma

“…Chronic lymphocytic leukemia (CLL) is the most common mature B-cell neoplasm in the West. IGHV4-34 is one of the most frequently used genes in CLL patients,…”
Get full text

Accessing Novel Therapies for Aggressive Lymphoma by Pavlovsky, Astrid

Get full text

Relapse or refractory Hodgkin lymphoma: determining risk of relapse or progression after autologous stem-cell transplantation by Bentolila, Gonzalo, Pavlovsky, Astrid

“…The treatment of classic Hodgkin lymphoma (HL) is a success in onco-hematology. Despite the high cure rate of HL with initial therapy, 5-10% of patients are…”
Get full text

Classic Hodgkin lymphoma by Kahn, Justine, Dabaja, Bouthaina, Wu, Susan, Kelly, Kara, Berkahn, Leanne, Pavlovsky, Astrid, Sureda, Anna, LaCasce, Ann

“…Classic Hodgkin lymphoma (HL) is rare disease, with an incidence of approximately 85,000 patients globally per year and a predilection for adolescents and…”
Get full text

Comparison of Outcome of Adolescents with Newly Diagnosed Hodgkin Lymphoma (HL) in Argentina, Treated within a Pediatric Vs an Adults Clinical Trial : Experience of the Gatla Group by Veron, David Alejandro, Streitenberger, Patricia, Freigeiro, Daniel, Pavlovsky, Astrid

“…Introduction: There are no prospective clinicaltrials directly comparing results of pediatric and adult treatment approaches in adolescents with HL. We report…”
Get full text

Impact of Ibrutinib in Quality of Life (QoL) in Patients with Chronic Lymphocytic Leukemia(CLL): Real World Experience in Argentina by Mela Osorio, María Jose, Pavlovsky, Astrid, Pavlovsky, Carolina, Fernandez, Isolda I, Clavijo, Manuela, Miroli, Augusto, Sackmann, Federico, Remaggi, Guillermina, Ferrari, Luciana C, Juni, Mariana, Sighel, Carolina, Riddick, Maximiliano, Pavlovsky, Miguel Arturo

Get full text

SUNMO: A phase III trial evaluating the efficacy and safety of mosunetuzumab in combination with polatuzumab vedotin vs rituximab plus gemcitabine and oxaliplatin in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma by Westin, Jason, Olszewski, Adam J, Fogliatto, Laura, Kim, Won Seog, Shin, Ho-Jin, Jeon, Young-Woo, Norasetthada, Lalita, Pavlovsky, Astrid, Rego, Eduardo, Wu, Hao, Yin, Shen, Batlevi, Connie Lee, Pham, Song, Penuel, Elicia M., Jing, Jing, Wei, Michael C., Budde, Lihua Elizabeth

“…TPS7586 Background: Aggressive non-Hodgkin lymphomas (aNHL) are a diverse group of neoplasms, of which diffuse large B-cell lymphoma (DLBCL) is the most common…”
Get full text

Benefits of BV-AVD (Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine) versus ABVD (doxorubicin hydrochloride, bleomycin sulfate, vinblastine sulfate, dacarbazine) in patients with advanced-stage Hodgkin's lymphoma: an analysis of the ECHELON 1 trial by the GATLA group using the Delphi Method by Pavlovsky, Astrid, Altuve, Juan Ignacio Garcia, Cerutti, Amalia, Fiad, Lorena, Kurgansky, Nicolás, Warley, Fernando, Negri Aranguren, Florencia

“…The BV-AVD (Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine) combination for first-line treatment of advanced stage Hodgkin's lymphoma has been…”
Get full text

Superior prognostic accuracy of FIGO staging system in primary female genital tract lymphomas: A retrospective study (IELSG35) by Pirosa, Maria Cristina, Steffanoni, Sara, Vanazzi, Anna, Esposito, Fabiana, Polino, Angela, Schena, Alberto, Landi, Francesco, Cabrera, Maria Elena, Akhtar, Saad, Gardella, Santiago, Bairey, Osnat, Pavlovsky, Astrid, Stathis, Anastasios, Zucca, Emanuele

“…Primary lymphoma of the female genital tract (PLFGT) is a rare type of extranodal lymphoma. In this retrospective study from the International Extranodal…”
Get full text

Women in Lymphoma: A 4-year journey in promoting gender equity by Trotman, Judith, LaCasce, Ann, Osborne, Wendy, Steiner, Anna, Hawkes, Eliza, Casulo, Carla

Get full text

Epidemiology, Clinical Features and Outcomes of Peripheral T-Cell Lymphoma in Latin America by Fischer, Thais, Idrobo, Henry, Pavlovsky, Astrid, Castro, Denisse, Beltran, Brady, Enriquez, Daniel J, Vasquez, Jule F, Roche, Claudia, Artiles, Daniel, Valvert, Fabiola, Villela, Luis Mario, Pereira, Juliana, Oliver, Carolina, Tavarez, Jamila Vaz, Brasil, Sergio Augusto B, Cecyn, Karin Z, Castro, Nelson, Baptista, Renata, Medina, Samuel de S, Borducchi, Davimar Miranda Maciel, Bellesso, Marcelo, De Farias, Danielle Leao Cordeiro, Gonzaga, Yung Bruno, Warley, Fernando, Fiad, Lorena, Korin, Laura, Pereyra, Patricio Hernan, Peña, Camila, Torres, Maria Alejandra, Mahuad, Carolina Valeria, Von Glasenapp, Alana, Quiroz, Alfredo Reinaldo, Gazitua, Raimundo, Samanez-Figari, Cesar Augusto, Sardu, Lautaro, Arriola, Juan Pablo, Isnardi, Sebastian, Maradei, Juan L., Gabus, Raul Hector, Enrico, Alicia I., Guanchiale, Luciana A, Arangueren, Florencia Negri, Altuve, Juan Ignacio García, Cerutti, Amalia, Penalva, Romina, Trucco, Jose Ignacio Garcia, Pessolani, Florencia, Gilli, Virginia, Diaz, Joaquin, Martinez, Maria Enriqueta, Jarchum, Gustavo, Perinotto, Gabriela Celia, Barraza, Teresa, Ciarlo, Sergio, Rojas, Christine, Rios Jiménez, Rosa Oliday, De Souza, Carmino, Manni, Martina, Miranda, Eliana C M CM, Federico, Massimo, Valcarcel, Bryan, Chiattone, Carlos, Malpica Castillo, Luis Enrique

“…INTRODUCTION: Peripheral T-cell lymphomas (PTCL) represent a rare and heterogenous group of mature T-cell lymphomas often characterized by aggressive behavior…”
Get full text

Long‐term outcome of peripheral T‐cell lymphomas: Ten‐year follow‐up of the International Prospective T‐cell Project by Civallero, Monica, Schroers‐Martin, Joseph G., Horwitz, Steven, Manni, Martina, Stepanishyna, Yana, Cabrera, Maria Elena, Vose, Julie, Spina, Michele, Hitz, Felicitas, Nagler, Arnon, Montoto, Silvia, Chiattone, Carlos, Skrypets, Tetiana, Perez Saenz, M. Angeles, Priolo, Giorgio, Luminari, Stefano, Lymboussaki, Athina, Pavlovsky, Astrid, Marino, Dario, Liberati, Marina, Trotman, Judith, Mannina, Donato, Federico, Massimo, Advani, Ranjana

“…Summary Peripheral T‐cell lymphomas (PTCLs) are a heterogeneous group of haematological cancers with generally poor clinical outcomes. However, a subset of…”
Get full text

Long-Term Outcomes and Health-Related Quality of Life (HRQoL) By Response Status for Bortezomib, Melphalan, and Prednisone (VMP) ± Daratumumab (DARA) in Alcyone by Rodriguez-Otero, Paula, Boccadoro, Mario, Hajek, Roman, Fujisaki, Tomoaki, Lee, Jae Hoon, Martinez-Lopez, Joaquin, Lucio, Paulo, Nagy, Zsolt, Usenko, Ganna, Liberati, Anna Marina, Lazaroiu, Mihaela, Woszczyk, Dariusz, Takamatsu, Hiroyuki, Romejko-Jarosinska, Joanna, Knop, Stefan Tobias, Pavlovsky, Astrid, Forsyth, Cecily, Ishikawa, Takayuki, Gries, Katharine S., Pei, Huiling, Kudva, Anupa, Ukropec, Jon, Wroblewski, Susan, Carson, Robin, Dimopoulos, Meletios A

“…Introduction: DARA is a human IgGκ monoclonal antibody targeting CD38 with a direct on-tumor and immunomodulatory mechanism of action. In the phase 3 ALCYONE…”
Get full text

T-cell lymphomas in South america and europe by Bellei, Monica, Chiattone, Carlos Sergio, Luminari, Stefano, Pesce, Emanuela Anna, Cabrera, Maria Elena, de Souza, Carmino Antonio, Gabús, Raul, Zoppegno, Lucia, Milone, Jorge, Pavlovsky, Astrid, Connors, Joseph Michael, Foss, Francine Mary, Horwitz, Steven Michael, Liang, Raymond, Montoto, Silvia, Pileri, Stefano Aldo, Polliack, Aaron, Vose, Julie Marie, Zinzani, Pier Luigi, Zucca, Emanuele, Federico, Massimo

“…Peripheral T-cell lymphomas are a group of rare neoplasms originating from clonal proliferation of mature post-thymic lymphocytes with different entities…”
Get full text

Abbreviated Regimen with 4 Cycles of Fludarabine, Cyclophosphamide and Rituximab (FCR) in Physically Fit Patients with Chronic Lymphocytic Leukemia Who Achieve Early Complete Remission with Undetectable Minimal Residual Disease: Safety and Efficacy Follow-up Results of a Single Center Experience by Pavlovsky, Carolina, Fernandez, Isolda, Pavlovsky, Miguel A, Galeano, Adriana, Sackmann, Federico, Intile, Dante, Pavlovsky, Astrid

“…Introduction: Chemoimmunotherapy with 6 cycles of fludarabine, cyclophosphamide and rituximab (FCR) is considered standard therapy for physically fit patients…”
Get full text

Personalised therapy in follicular lymphoma - is the dial turning? by Linton, Kim M, Specht, Lena, Pavlovsky, Astrid, Thompson, Carrie A, Kimby, Eva, de Jong, Daphne, Nastoupil, Loretta J, Cottereau, Anne-Ségolène, Casulo, Carla, Sarkozy, Clémentine, Okosun, Jessica

“…Follicular lymphoma is the most common indolent lymphoma accounting for approximately 20%-25% of all new non-Hodgkin lymphoma diagnoses in western countries…”
Get full text

PET‐adapted therapy after three cycles of ABVD for all stages of Hodgkin lymphoma: results of the GATLA LH‐05 trial by Pavlovsky, Astrid, Fernandez, Isolda, Kurgansky, Nicolas, Prates, Virginia, Zoppegno, Lucia, Negri, Pedro, Milone, Gustavo, Cerutti, Ider, Zabaljauregui, Soledad, Mariano, Romina, Grecco, Horacio F., Basquiera, Ana L., Saba, Silvia, Rudoy, Silvia, Sackmann, Federico, Castano, Vanesa, Remaggi, Guillermina, Cabrejo, Maria, Roveri, Eriberto, Casale, Maria F., Cabane, Vanina, Taus, Rossana, Venturini, Claudia, Sakamoto, Francisco, Varela, Ana I., Riddick, Maximiliano, Pavlovsky, Santiago

“…Summary The role of Ann Arbor staging in determining treatment intensity after achieving a negative positron emission tomography (PET) has not been established…”
Get full text

SOXC and MiR17-92 gene expression profiling defines two subgroups with different clinical outcome in mantle cell lymphoma by Roisman, Alejandro, Huamán Garaicoa, Fuad, Metrebian, Fernanda, Narbaitz, Marina, Kohan, Dana, García Rivello, Hernán, Fernandez, Isolda, Pavlovsky, Astrid, Pavlovsky, Miguel, Hernández, Luis, Slavutsky, Irma

“…Mantle cell lymphoma (MCL) is a heterogeneous B‐cell lymphoid malignancy where most patients follow an aggressive clinical course whereas others are associated…”
Get full text

TCL-348: Breast-Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): First Latinomerican Report by Tannuri, Ricardo, Pavlovsky, Miguel, Pavlovsky, Astrid, Fernández, Isolda, Colombo, Martín, Giuliani, Franco, Mela Osorio, María, Narbaitz, Marina, Remaggi, Guillermina, Basso, Alfredo, Otero, Victoria, Rodriguez, Ana, Zerga, Marta

“…BIA-ALCL is a new entity included in the 2016 WHO classification. It represents less than 10% of breast lymphomas. There are approximately 500 cases reported…”
Get full text

Safety and Efficacy Of Abbreviated Induction With Only 4 Cycles Of Fludarabine (F), Cyclophosphamide (C) and Rituximab (R) In Physically Fit Patients With Chronic Lymphocytic Leukemia (CLL) Who Achieve Early Complete Remission (CR) With Undetectable Minimal Residual Disease (MDR) by Pavlovsky, Carolina, Pavlovsky, Astrid, Fernandez, Isolda, Galeano, Adriana, Lastiri, Francisco, Pavlovsky, Santiago

“…Chemoimmunotherapy with 6 cycles of FCR is considered standard therapy for physically fit patients (pts) with Chronic Lymphocytic Leukemia (CLL). Many pts are…”
Get full text